Sign in
4

Changes in Ownership

Inmune Bio, Inc. Filed Acc 0001213900-24-035472

Chief Scientific Officer acquired 14,423 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Lowdell Mark William · Chief Scientific Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-19 Grant or award : show line 1 in the form +14,423 $8.32 $119,999 1,510,806 D

Table II: Derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-04-19 Grant or award : show line 2 in the form Common Stock Warrants (right to buy) +14,423 $0.13 $1,803 14,423 D
Loading xslF345X05/ownership.xml…